5Paris M, Porcelloni M, Binaschi M, et al. Histone deacetylase inhibitors: from bench to clinic [ J ]. J Med Chem, 2008,51:1505-1529
6Villar-Garea A, Imhof A. The analysis of histone modifications [ J ]. Biochim Biophys Acta,2006, 1764,: 1932-1939
7Marchion D, Mtinster P. Development of histone deacetylase inhibitors for cancer treatment [ J ]. Expert Rev Anticancer Ther,2007 ,7 :583-598
8Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat:development of this histone deacetylase inhibitor as an anticancer drug [ J ]. Nat Biotechno1,2007,25 : 84-90
9Darkin-Rattray SJ, Gurnett AM, Myers RW, et al. Apicidin:a novel antiprotozoal agent that inhibits parasite histone deacetylase[ J]. Proc Natl Acad Sci U S A, 1996, 93 : 13143-13147
10Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer[J]. Nat Rev Cancer,2006,6:38-51
